Connect with us

Company News

Agenus regains compliance with Nasdaq MBP requirement

Agenus Inc. received notice from NASDAQ on April 30, 2024, that the Company has regained compliance with the $1.00 minimum bid price requirement set forth in NASDAQ Listing Rule 5550(a)(2). Accordingly, the Company now satisfies all requirements for continued listing on the NASDAQ Capital Market and the matter is now closed.
MB Bureau

Copyright © 2024 Medical Buyer maintained by Fullstack development